학술논문

HERACLIS-TAF: a multi-centre prospective cohort study on 2-year safety and efficacy of tenofovir alafenamide in patients with chronic hepatitis B with renal and/or bone disorders or risks
Document Type
Article
Source
In: Alimentary Pharmacology and Therapeutics. (Alimentary Pharmacology and Therapeutics, August 2022, 56(4):702-712)
Subject
Language
English
ISSN
13652036
02692813